Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Database
Language
Publication year range
1.
PLoS One ; 13(6): e0195903, 2018.
Article in English | MEDLINE | ID: mdl-29897914

ABSTRACT

Seasonal influenza is a contagious respiratory illness that annually affects millions of people worldwide. To identify currently circulating influenza virus subtypes, the Centers for Disease Control and Prevention's International Reagent Resource distributes the World Health Organization (WHO) influenza reagent kits, which are used globally by testing laboratories for influenza surveillance. The data generated by the kits aid in strain selection for the influenza vaccine each season. The use of animals to produce high quality and quantities of antibodies is critical to the production of these kits. In this study, we assessed the effects and efficacy of repeated sampling from automated plasmapheresis in goats. Analysis of blood samples demonstrated that repeated automated plasmapheresis procedures did not adversely affect the immediate or long-term health of goats. Further, our results indicate that repeated plasmapheresis in goats was capable of generating 2 liters of antibody-rich plasma per goat per week. This volume is sufficient to produce enough WHO influenza kits to conduct over 1 million tests. Thus, we have shown that the rapid production of plasma in goats can positively impact the public health preparedness and response to influenza.


Subject(s)
Antibodies, Viral/blood , Antibodies, Viral/isolation & purification , Goats/blood , Hemagglutinin Glycoproteins, Influenza Virus/pharmacology , Influenza Vaccines/pharmacology , Plasmapheresis , Vaccination , Animals , Antibodies, Viral/immunology , Goats/immunology , Influenza Vaccines/immunology
2.
Am J Vet Res ; 78(6): 752-756, 2017 Jun.
Article in English | MEDLINE | ID: mdl-28541146

ABSTRACT

OBJECTIVE To assess the immunogenicity of thermostable live-attenuated rabies virus (RABV) preserved by vaporization (PBV) and delivered to the duodenal mucosa of a wildlife species targeted for an oral vaccination program. ANIMALS 8 gray foxes (Urocyon cinereoargenteus). PROCEDURES Endoscopy was used to place RABV PBV (n = 3 foxes), alginate-encapsulated RABV PBV (3 foxes), or nonpreserved RABV (2 foxes) vaccine into the duodenum of foxes. Blood samples were collected weekly to monitor the immune response. Saliva samples were collected weekly and tested for virus shedding by use of a conventional reverse-transcriptase PCR assay. Foxes were euthanized 28 days after vaccine administration, and relevant tissues were collected and tested for presence of RABV. RESULTS 2 of 3 foxes that received RABV PBV and 1 of 2 foxes that received nonpreserved RABV seroconverted by day 28. None of the 3 foxes receiving alginate-encapsulated RABV PBV seroconverted. No RABV RNA was detected in saliva at any of the time points, and RABV antigen or RNA was not detected in any of the tissues obtained on day 28. None of the foxes displayed any clinical signs of rabies. CONCLUSIONS AND CLINICAL RELEVANCE Results for this study indicated that a live-attenuated RABV vaccine delivered to the duodenal mucosa can induce an immune response in gray foxes. A safe, potent, thermostable RABV vaccine that could be delivered orally to wildlife or domestic animals would enhance current rabies control and prevention efforts.


Subject(s)
Duodenum , Foxes , Immunogenicity, Vaccine , Rabies Vaccines/immunology , Administration, Oral , Animals , Animals, Wild , Antigens, Viral , Duodenoscopy/veterinary , Duodenum/immunology , Female , Intestinal Mucosa/immunology , Male , Rabies Vaccines/administration & dosage , Vaccines, Attenuated/immunology , Volatilization
3.
Vet Parasitol ; 210(1-2): 91-7, 2015 May 30.
Article in English | MEDLINE | ID: mdl-25881801

ABSTRACT

Since 2005, black-tailed prairie dogs (Cynomys ludovicianus) have been collected for use as research animals from field sites in Kansas, Colorado, and Texas. In January of 2012, Giardia trophozoites were identified by histology, thin-section electron microscopy, and immunofluorescent staining in the lumen of the small intestine and colon of a prairie dog euthanized because of extreme weight loss. With giardiasis suspected as the cause of weight loss, a survey of Giardia duodenalis in the laboratory colony of prairie dogs was initiated. Direct immunofluorescent testing of feces revealed active shedding of Giardia cysts in 40% (n=60) of animals held in the vivarium. All tested fecal samples (n=29) from animals in another holding facility where the index case originated were PCR positive for G. duodenalis with assemblages A and B identified from sequencing triosephosphate isomerase (tpi), glutamate dehydrogenase (gdh), and ß-giardin (bg) genes. Both assemblages are considered zoonotic, thus the parasites in prairie dogs are potential human pathogens and indicate prairie dogs as a possible wildlife reservoir or the victims of pathogen spill-over. Molecular testing for other protozoan gastrointestinal parasites revealed no Cryptosporidium infections but identified a host-adapted Enterocytozoon bieneusi genotype group.


Subject(s)
Enterocytozoon/isolation & purification , Giardia lamblia/isolation & purification , Giardiasis/veterinary , Microsporidiosis/veterinary , Sciuridae/parasitology , Animals , DNA, Protozoan/genetics , Enterocytozoon/genetics , Feces/parasitology , Fenbendazole/therapeutic use , Giardia lamblia/genetics , Giardiasis/drug therapy , Giardiasis/parasitology , Laboratory Animal Science , Microsporidiosis/parasitology , Phylogeny , Polymerase Chain Reaction , Zoonoses
4.
PLoS One ; 9(12): e115105, 2014.
Article in English | MEDLINE | ID: mdl-25542001

ABSTRACT

Rocky Mountain spotted fever (RMSF) is a tick-borne disease caused by R. rickettsii in North and South America. Domestic dogs are susceptible to infection and canine RMSF can be fatal without appropriate treatment. Although clinical signs of R. rickettsii infection in dogs have been described, published reports usually include descriptions of either advanced clinical cases or experimental infections caused by needle-inoculation of cultured pathogen rather than by tick bite. The natural progression of a tick-borne R. rickettsii infection has not been studied in sufficient detail. Here, we provide a detailed description of clinical, hematological, molecular, and serological dynamics of RMSF in domestic dogs from the day of experimental exposure to infected ticks through recovery. Presented data indicate that neither the height/duration of fever nor detection of rickettsial DNA in dogs' blood by PCR are good indicators for clinical prognosis. Only the apex and subsequent subsidence of neutrophilia seem to mark the beginning of recovery and allow predicting a favorable outcome in Rickettsia-infected dogs, even despite the continuing persistence of mucosal petechiae and skin rash. On the other hand the appropriate (doxycycline) antibiotic therapy of sufficient duration is crucial in prevention of RMSF relapses in dogs.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Dog Diseases/blood , Dog Diseases/drug therapy , Doxycycline/therapeutic use , Rickettsia rickettsii/genetics , Rocky Mountain Spotted Fever/veterinary , Animals , Disease Models, Animal , Dog Diseases/microbiology , Dogs , Male , Prognosis , Recurrence , Rocky Mountain Spotted Fever/blood , Rocky Mountain Spotted Fever/drug therapy , Rocky Mountain Spotted Fever/microbiology , Tick Bites/blood , Tick Bites/drug therapy , Tick Bites/microbiology , Tick Bites/veterinary
5.
J Am Assoc Lab Anim Sci ; 49(3): 274-81, 2010 May.
Article in English | MEDLINE | ID: mdl-20587156

ABSTRACT

The black-tailed prairie dog (Cynomys ludovicianus) is a member of the order Rodentia and the family Sciuridae. Ecologically, prairie dogs are a keystone species in prairie ecology. This species is used as an animal model for human gallbladder disease and diseases caused by infection with Clostridium difficile, Yersinia pestis, Francisella tularensis, and most recently, Orthopoxvirus. Despite increasing numbers of prairie dogs used in research and kept as pets, few data are available on their baseline physiology in animal facility housing conditions. To establish baseline physiologic reference ranges, we designed a study using 18 wild-caught black-tailed prairie dogs. Telemetry data were analyzed to establish circadian rhythms for activity and temperature. In addition, hematologic and serum chemistry analyses were performed. Baseline measurements were used to establish the mean for each animal, which then were compiled and analyzed to determine the reference ranges. Here we present physiologic data on serum chemistry and hematology profiles, as well as weight, core body temperature, and daily activity patterns for black-tailed prairie dogs. These results reflect the use of multiple measurements from species- and age-matched prairie dogs and likely will be useful to ecologists, scientists interested in using this animal model in research, and veterinarians caring for pet prairie dogs.


Subject(s)
Sciuridae/physiology , Animals , Body Temperature , Body Weight , Circadian Rhythm , Female , Male , Reference Values , Sciuridae/anatomy & histology , Sciuridae/blood , Sciuridae/microbiology , Telemetry
6.
J Am Assoc Lab Anim Sci ; 45(6): 44-8, 2006 Nov.
Article in English | MEDLINE | ID: mdl-17089991

ABSTRACT

Reactions to allergens created by laboratory animals are among the most frequently encountered occupational illnesses associated with research animals. Personnel are exposed to these allergens through airborne particulate matter. Although the use of microisolation caging systems can reduce particulate matter concentrations in rooms housing mice, the operating parameters of ventilated caging systems vary extensively. We compared room air in mouse rooms containing 5 different types of caging: 1) individually ventilated caging under positive pressure with filtered intake air and exhaust air returned to the room (VCR+), 2) individually ventilated caging under negative pressure with exhaust air returned to the room (VCR-), 3) individually ventilated caging under positive pressure with exhaust air returned to the heating, ventilation, and air-conditioning (HVAC) system, 4) individually ventilated caging under negative pressure with exhaust air returned to the HVAC system, and 5) static microisolation cages. We found that rooms under VCR conditions had fewer large particles than did those under other conditions, but the numbers of 0.3 microm particles did not differ significantly among systems. Static, positive or negative pressure applied to caging units as well as route of air exhaust were found to have little influence on the total number of particles in the atmosphere. Therefore, considering the heat load, odor, and overall particulate concentration in the room, placing individually ventilated caging under negative pressure with exhaust air returned to the HVAC system appears to be the optimal overall choice when using microisolation housing for rodents.


Subject(s)
Air Pollutants, Occupational/analysis , Housing, Animal/standards , Mice , Occupational Exposure/analysis , Particulate Matter/analysis , Animals , Environmental Monitoring , Housing, Animal/classification , Occupational Exposure/prevention & control , Ventilation/methods
7.
Hum Gene Ther ; 17(1): 31-45, 2006 Jan.
Article in English | MEDLINE | ID: mdl-16409123

ABSTRACT

In this study we examine the safety, feasibility, and biodistribution of a tumor-selective mutant vaccinia (vvDD) and wild-type WR (vF13) vaccinia after delivery via intradermal or intravenous infection or isolated limb perfusion (ILP) in rhesus macaques. By intradermal inoculation, 10(6) PFU of vvDD caused a minimal skin reaction whereas vF13 caused marked erythema and necrosis with a peak indurated area of 108 cm2. By intravenous delivery, vvDD caused no clinical symptoms of viremia and no viral recovery from tissues, serum, saliva, urine, or feces. In contrast, vF13 caused symptoms of lethargy, anorexia, fever, and signs of viremia. Delivery of vF13 via ILP resulted in numerous cutaneous pox lesions localized solely to the perfused limb with high viral recovery in the perfused skin and muscle. ILP with vvDD resulted in no visible pox lesions and no clinical signs or symptoms of viremia. No long-term toxicity was identified after ILP with 10(9) PFU of vvDD, and no virus was recovered from any tissue, serum, saliva, urine, or fecal sample. These results suggest that vvDD appears to be safe in primates, and thus vvDD should be further investigated for clinical trial in human cancer patients.


Subject(s)
Genetic Therapy/methods , Genetic Vectors/administration & dosage , Genetic Vectors/standards , Neoplasms/therapy , Vaccinia virus/physiology , Animals , Antibodies, Viral/blood , Extremities/virology , Female , Genetic Therapy/standards , Humans , Infusions, Intravenous/methods , Injections, Intradermal , Intercellular Signaling Peptides and Proteins , Interleukin-6/blood , Liver/chemistry , Liver/pathology , Macaca mulatta , Male , Mutation/genetics , Peptides/genetics , Perfusion/methods , Thymidine Kinase/genetics , Vaccinia virus/genetics , Vaccinia virus/immunology
8.
Mutat Res ; 583(2): 105-19, 2005 Jun 06.
Article in English | MEDLINE | ID: mdl-15927870

ABSTRACT

We utilized a non-human primate model, the rhesus monkey (Macaca mulatta), to quantitate the extent of chromosomal damage in bone marrow cells following chemotherapy. Thiotepa, etoposide, and paclitaxel were chosen as the chemotherapy agents due to their distinct mechanisms of action. Chromosomal aberrations were quantitated using traditional Giemsa stain. We sought to evaluate the extent to which genotoxicity was dependent on the schedule of administration by giving chemotherapy as either a bolus or a 96 h continuous infusion. Neutropenia and areas under the concentration curve (AUCs) were monitored to ensure comparable cytotoxicity and dose administered. At least 100 metaphases were scored in each marrow sample by an investigator unaware of the treatment history of the animals. All three drugs produced a statistically significant higher percentage of abnormal metaphases following bolus chemotherapy (p<0.0001, p=0.0015 and p<0.0001 for thiotepa, etoposide and paclitaxel, respectively). We conclude that infusional administration of thiotepa, etoposide and paclitaxel is less genotoxic to normal bone marrow cells than is bolus administration. These results suggest infusional regimens may be considered where there are concerns about long-term genotoxic sequelae, including secondary cancer, teratogenicity, or possibly the development of drug resistance. We believe this approach provides a reproducible model in which drugs and eventually, regimens can be compared.


Subject(s)
Bone Marrow Cells/pathology , Chromosome Aberrations/chemically induced , Drug-Related Side Effects and Adverse Reactions , Animals , Area Under Curve , Azure Stains , Chromosome Painting/methods , Dose-Response Relationship, Drug , Drug Administration Schedule , Etoposide/administration & dosage , Etoposide/adverse effects , Etoposide/pharmacokinetics , Infusions, Intravenous , Macaca mulatta , Neutropenia/pathology , Paclitaxel/administration & dosage , Paclitaxel/adverse effects , Paclitaxel/pharmacokinetics , Thiotepa/administration & dosage , Thiotepa/adverse effects , Thiotepa/pharmacokinetics
SELECTION OF CITATIONS
SEARCH DETAIL
...